financetom
Business
financetom
/
Business
/
State Street Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
State Street Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Apr 11, 2024 10:21 PM

State Street Corporation ( STT ) is set to release earnings results for its first quarter before the opening bell on April 12, 2024.

Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $1.50 per share, down from $1.52 per share in the year-ago period. State Street is projected to report quarterly revenue of $3.06 billion, compared to $3.1 billion in the year-earlier quarter, according to data from Benzinga Pro.

On Feb. 1, State Street completed its acquisition of CF Global Trading for an undisclosed amount.

State Street shares fell 0.6% to close at $73.91 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

RBC Capital analyst Gerard Cassidy maintained a Sector Perform rating and boosted the price target from $75 to $85 on Jan. 22, 2024. This analyst has an accuracy rate of 72%.

Keefe, Bruyette & Woods analyst Michael Brown maintained a Market Perform rating and cut the price target from $89 to $86 on Jan. 22, 2024. This analyst has an accuracy rate of 66%.

UBS analyst Brennan Hawken maintained a Neutral rating and boosted the price target of $70 to $82 on Jan. 9, 2024. This analyst has an accuracy rate of 69%.

B of A Securities analyst Ebrahim Poonawala downgraded the stock from Neutral to Underperform with a price target of $81 on Jan. 4, 2024. This analyst has an accuracy rate of 64%.

Goldman Sachs analyst Alexander Blostein upgraded the stock from Neutral to Buy with a price target of $92 on Jan. 3, 2024. This analyst has an accuracy rate of 71%.

 

Read This Next: Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved